BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 25873436)

  • 21. Validation of a one-page patient-reported Charlson comorbidity index questionnaire for upper aerodigestive tract cancer patients.
    Habbous S; Chu KP; Harland LT; La Delfa A; Fadhel E; Sun B; Xu W; Wong A; Howell D; Ringash J; Waldron J; O'Sullivan B; Goldstein D; Huang SH; Liu G
    Oral Oncol; 2013 May; 49(5):407-12. PubMed ID: 23291295
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of Socioeconomic Characteristics and Comorbidities on Therapy Initiation and Outcomes of Newly Diagnosed Multiple Myeloma: Real-World Data From a Resource-Constrained Setting.
    Vargas-Serafin C; Acosta-Medina AA; Ordonez-Gonzalez I; Martínez-Baños D; Bourlon C
    Clin Lymphoma Myeloma Leuk; 2021 Mar; 21(3):182-187. PubMed ID: 33414064
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Combination of Frailty Status and Comorbidity Score Improves the Stratification of Survival in Patients With Myelodysplastic Syndrome Owing to Good Predictive Capability for Infection-related Mortality.
    Sakatoku K; Takeoka Y; Miura A; Araki T; Fujitani Y; Yamamura R; Nakamae H; Ohta K; Hino M
    Clin Lymphoma Myeloma Leuk; 2019 Dec; 19(12):799-805. PubMed ID: 31648956
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comorbidity is an independent prognostic factor in patients with advanced-stage diffuse large B-cell lymphoma treated with R-CHOP: a population-based cohort study.
    Wieringa A; Boslooper K; Hoogendoorn M; Joosten P; Beerden T; Storm H; Kibbelaar RE; Veldhuis GJ; van Kamp H; van Rees B; Kluin-Nelemans HC; Veeger NJ; van Roon EN
    Br J Haematol; 2014 May; 165(4):489-96. PubMed ID: 24754632
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A multidimensional approach to the geriatric patient with chronic kidney disease.
    Pilotto A; Sancarlo D; Franceschi M; Aucella F; D'Ambrosio P; Scarcelli C; Ferrucci L
    J Nephrol; 2010; 23 Suppl 15():S5-10. PubMed ID: 20872364
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of the prognostic significance of 5 comorbidity scores and 12 functional tests in a prospective multiple myeloma patient cohort.
    Scheubeck S; Ihorst G; Schoeller K; Holler M; Möller MD; Reinhardt H; Wäsch R; Engelhardt M
    Cancer; 2021 Sep; 127(18):3422-3436. PubMed ID: 34061991
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative analysis of comorbidity and performance indices for prediction of oncological outcomes in patients with upper tract urothelial carcinoma who were treated with radical nephroureterectomy.
    Aziz A; Fritsche HM; Gakis G; Kluth LA; Hassan Fa; Engel O; Dahlem R; Otto W; Gierth M; Denzinger S; Schwentner C; Stenzl A; Shariat SF; Fisch M; Burger M; Rink M
    Urol Oncol; 2014 Nov; 32(8):1141-50. PubMed ID: 24856977
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fatigue is associated with serum interleukin-6 levels and symptoms of depression in patients on chronic hemodialysis.
    Bossola M; Di Stasio E; Giungi S; Rosa F; Tazza L
    J Pain Symptom Manage; 2015 Mar; 49(3):578-85. PubMed ID: 25135658
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Validation of the Charlson Comorbidity Index in acutely hospitalized elderly adults: a prospective cohort study.
    Frenkel WJ; Jongerius EJ; Mandjes-van Uitert MJ; van Munster BC; de Rooij SE
    J Am Geriatr Soc; 2014 Feb; 62(2):342-6. PubMed ID: 24521366
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevalence of functional disability in activities of daily living (ADL), instrumental activities of daily living (IADL) and associated factors, as predictors of morbidity and mortality.
    Millán-Calenti JC; Tubío J; Pita-Fernández S; González-Abraldes I; Lorenzo T; Fernández-Arruty T; Maseda A
    Arch Gerontol Geriatr; 2010; 50(3):306-10. PubMed ID: 19520442
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Frailty and other geriatric conditions for risk stratification of older patients with acute coronary syndrome.
    Sanchis J; Bonanad C; Ruiz V; Fernández J; García-Blas S; Mainar L; Ventura S; Rodríguez-Borja E; Chorro FJ; Hermenegildo C; Bertomeu-González V; Núñez E; Núñez J
    Am Heart J; 2014 Nov; 168(5):784-91. PubMed ID: 25440808
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The prognostic effects of two comprehensive geriatric assessment methods in elderly patients with acute myeloid leukemia].
    Zhang S; Feng R; Li JT; Wang T; Zhang CL; Bai JF; Li Y; Shao RY; Liu H
    Zhonghua Nei Ke Za Zhi; 2021 Oct; 60(10):880-885. PubMed ID: 34551476
    [No Abstract]   [Full Text] [Related]  

  • 33. Prognostic significance of apoptotic index in multiple myeloma patients treated by conventional therapy and novel agents, thalidomide and bortezomib.
    Minarik J; Scudla V; Ordeltova M; Bacovsky J; Pika T; Langova K
    Eur J Haematol; 2009 Dec; 83(6):528-34. PubMed ID: 19624720
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Demented versus non-demented very old inpatients: the same comorbidities but poorer functional and nutritional status.
    Zekry D; Herrmann FR; Grandjean R; Meynet MP; Michel JP; Gold G; Krause KH
    Age Ageing; 2008 Jan; 37(1):83-9. PubMed ID: 17971391
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Incorporation of the bone marker carboxy-terminal telopeptide of type-1 collagen improves prognostic information of the International Staging System in newly diagnosed symptomatic multiple myeloma.
    Jakob C; Sterz J; Liebisch P; Mieth M; Rademacher J; Goerke A; Heider U; Fleissner C; Kaiser M; von Metzler I; Müller C; Sezer O
    Leukemia; 2008 Sep; 22(9):1767-72. PubMed ID: 18580957
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The relationship of multimorbidity with disability and frailty in the oldest patients: a cross-sectional analysis of three measures of multimorbidity in the BELFRAIL cohort.
    Boeckxstaens P; Vaes B; Legrand D; Dalleur O; De Sutter A; Degryse JM
    Eur J Gen Pract; 2015 Mar; 21(1):39-44. PubMed ID: 24980394
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comorbidities and FLT3-ITD abnormalities as independent prognostic indicators of survival in elderly acute myeloid leukaemia patients.
    Breccia M; Frustaci AM; Cannella L; Stefanizzi C; Latagliata R; Cartoni C; Diverio D; Guarini A; Nanni M; Rago A; Cimino G; Alimena G
    Hematol Oncol; 2009 Sep; 27(3):148-53. PubMed ID: 19274612
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of comorbidity on survival for locally advanced head and neck cancer patients treated by radiotherapy or radiotherapy plus chemotherapy.
    Liu CT; Chiu TJ; Huang TL; Chien CY; Fang FM
    Chang Gung Med J; 2010; 33(3):283-91. PubMed ID: 20584506
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Influence of comorbidity and cognitive status on instrumental activities of daily living in amnestic mild cognitive impairment: results from the ReGAl project.
    Mariani E; Monastero R; Ercolani S; Rinaldi P; Mangialasche F; Costanzi E; Vitale DF; Senin U; Mecocci P;
    Int J Geriatr Psychiatry; 2008 May; 23(5):523-30. PubMed ID: 18058828
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The evaluation of the presence of comorbidity by the Marigliano-Cacciafesta polypathology scale (MCPS) and the cumulative illness rating scale (CIRS) in elderly subjects with disability.
    Martocchia A; Indiano I; Tafaro L; Frugoni P; Amici A; Cacciafesta M; Marigliano V; Falaschi P
    Arch Gerontol Geriatr; 2009; 49(1):150-2. PubMed ID: 18674825
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.